FDA Approves First Drug to Treat Full Range of Narcolepsy Type 1 Symptoms

The U.S. Food and Drug Administration (FDA) has approved the first drug designed to treat the full spectrum of symptoms associated with Narcolepsy Type 1. This regulatory action aims to provide a more comprehensive treatment option for patients with this chronic neurological condition.